Association between predicted FVIII levels and risk of bleeding episodes in clinical trials with turoctocog alfa, a new rFVIII product from Novo Nordisk

Ozelo, MC; Veljkovic, Dobrila K; Klamroth, R; Misgav, M; Nielsen, R; Groth, A

Results

eNauka > Results > Association between predicted FVIII levels and risk of bleeding episodes in clinical trials with turoctocog alfa, a new rFVIII product from Novo Nordisk

Title:	Association between predicted FVIII levels and risk of bleeding episodes in clinical trials with turoctocog alfa, a new rFVIII product from Novo Nordisk
Authors:	Ozelo, MC; Veljkovic, Dobrila K; Klamroth, R; Misgav, M; Nielsen, R; Groth, A
Issue Date:	2013
Publication:	JOURNAL OF THROMBOSIS AND HAEMOSTASIS
ISSN:	1538-7933 Journal of Thrombosis and Haemostasis Search Idenfier
Type:	Conference Paper
Collation:	vol. 11 str. 355-356
WoS-ID:	000331833602134
URI:	https://enauka.gov.rs/handle/123456789/812170
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM